An anti-parasitic drug, delivered on a mass scale, can prevent potentially dangerous bacterial complications of scabies in Fiji, according to a new study.
The research led by the Murdoch Children’s Research Institute (MCRI), the Kirby Institute at UNSW Sydney and the Ministry of Health and